BOOK
Special Techniques and Technical Advances in PET/CT Imaging, An Issue of PET Clinics, E-Book
(2016)
Additional Information
Book Details
Abstract
This issue of PET Clinics focuses on Special Techniques and Technical Advances in PET/CT Imaging. Articles will include: PET/CT Guided FNAC/Biopsy; Dual Time Point Imaging; Overview of Conventional imaging based intervention in clinical practice; Special Techniques in PET/CT in evaluating genito-urinary malignances; Special techniques in PET/CT imaging for evaluation of head and neck cancer; PET/CT enteroclysis; Contrast media in PET/CT imaging; PET/CT guided RFA; Non-attenuated corrected PET/CT imaging and applications; and more!
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Special Techniques and Technical Advances in \rPET/CT Imaging | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITOR | iii | ||
| EDITOR | iii | ||
| AUTHORS | iii | ||
| Contents | v | ||
| Preface: Special Techniques and Technical Advances in PET/Computed Tomographic Imaging\r | v | ||
| Overview of Conventional Imaging-based Intervention in Clinical Practice\r | v | ||
| Special Techniques in PET/Computed Tomography Imaging for Evaluation of Head and Neck Cancer\r | v | ||
| Recent Advances in Imaging of Small and Large Bowel \r | v | ||
| Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies \r | v | ||
| Role of PET/Computed Tomography in Radiofrequency Ablation for Malignant Pulmonary Tumors\r | vi | ||
| Fluorodeoxyglucose-PET/Computed Tomography–Guided Biopsy\r | vi | ||
| Dual-time-point Imaging and Delayed-time-point Fluorodeoxyglucose-PET/Computed\rTomography Imaging in Various Clinical Settings\r | vi | ||
| Contrast Media in PET/Computed Tomography Imaging\r | vii | ||
| PET CLINICS\r | viii | ||
| FORTHCOMING ISSUES | viii | ||
| April 2016 | viii | ||
| July 2016 | viii | ||
| October 2016 | viii | ||
| RECENT ISSUES | viii | ||
| October 2015 | viii | ||
| July 2015 | viii | ||
| April 2015 | viii | ||
| PROGRAM OBJECTIVE | ix | ||
| TARGET AUDIENCE | ix | ||
| LEARNING OBJECTIVES | ix | ||
| ACCREDITATION | ix | ||
| DISCLOSURE OF CONFLICTS OF INTEREST | ix | ||
| UNAPPROVED/OFF-LABEL USE DISCLOSURE | ix | ||
| TO ENROLL | ix | ||
| METHOD OF PARTICIPATION | ix | ||
| CME INQUIRIES/SPECIAL NEEDS | ix | ||
| Preface: Special Techniques and Technical Advances in PET/Computed Tomographic Imaging\r | xi | ||
| Overview of Conventional Imaging-based Intervention in Clinical Practice | 1 | ||
| Key points | 1 | ||
| INTRODUCTION | 1 | ||
| GENERAL CONSIDERATIONS | 1 | ||
| The Importance of Guidance | 1 | ||
| Choosing the Imaging Modality | 2 | ||
| Instrumentation and Technique | 2 | ||
| Fine-needle aspiration biopsy | 2 | ||
| Core biopsy | 3 | ||
| Coaxial system | 4 | ||
| Technical Maneuvers | 4 | ||
| PATIENT PREPARATION | 4 | ||
| Fasting | 4 | ||
| Preprocedural Laboratory Evaluation | 5 | ||
| Medications | 5 | ||
| Time-out | 5 | ||
| Pain Control | 5 | ||
| Postprocedural Care | 5 | ||
| LIVER | 5 | ||
| KIDNEYS | 6 | ||
| SPLEEN | 6 | ||
| OMENTAL/MESENTERIC/RETROPERITONEAL MASSES | 7 | ||
| PELVIC NODES | 7 | ||
| TUMOR ABLATION | 8 | ||
| Radiofrequency Ablation | 8 | ||
| Cryoablation | 9 | ||
| Role of PET–Computed Tomography | 10 | ||
| SUMMARY | 10 | ||
| REFERENCES | 10 | ||
| Special Techniques in PET/Computed Tomography Imaging for Evaluation of Head and Neck Cancer | 13 | ||
| Key points | 13 | ||
| INTRODUCTION | 13 | ||
| PUFFED-CHEEK TECHNIQUE | 14 | ||
| Method | 14 | ||
| Indications | 14 | ||
| OPEN-MOUTH TECHNIQUE | 15 | ||
| Method | 15 | ||
| Indications | 15 | ||
| MODIFIED VALSALVA MANEUVER | 16 | ||
| Recent Advances in Imaging of Small and Large Bowel | 21 | ||
| Key points | 21 | ||
| INTRODUCTION | 21 | ||
| EVALUATION OF THE BOWEL | 21 | ||
| CROSS-SECTIONAL IMAGING | 22 | ||
| Computed Tomography | 22 | ||
| Routine Computed Tomography Abdomen | 22 | ||
| Computed Tomographic Colonography | 22 | ||
| PET with Fludeoxyglucose F 18/Computed Tomography | 22 | ||
| Technique of PET with Fludeoxyglucose F 18/Computed Tomography Enterography | 22 | ||
| Technique of PET with Fludeoxyglucose F 18/Computed Tomography Colonography | 23 | ||
| PET with Fludeoxyglucose F 18/Computed Tomography Radiation Issues | 23 | ||
| MR Imaging | 23 | ||
| Diffusion-Weighted Imaging | 24 | ||
| Interpretation of Bowel Pathology on Cross-sectional Imaging | 24 | ||
| The normal bowel | 24 | ||
| PATHOLOGIC ABNORMALITIES | 25 | ||
| Tuberculosis | 25 | ||
| Malabsorption Syndromes | 26 | ||
| INFLAMMATORY BOWEL DISEASES | 26 | ||
| Crohn Disease | 26 | ||
| Ulcerative Colitis | 27 | ||
| PET WITH FLUDEOXYGLUCOSE F 18/COMPUTED TOMOGRAPHY IN INFLAMMATORY BOWEL DISEASE | 28 | ||
| Neutropenic Colitis | 29 | ||
| SMALL BOWEL NEOPLASMS | 30 | ||
| Adenocarcinoma | 30 | ||
| Carcinoid | 30 | ||
| Non-Hodgkin Lymphoma | 31 | ||
| Gastrointestinal Stromal Tumors | 31 | ||
| Metastases | 32 | ||
| PET with Fludeoxyglucose F 18/Computed Tomography in Small Bowel Neoplasms | 33 | ||
| Colonic Carcinoma | 33 | ||
| PET with Fludeoxyglucose F 18/Computed Tomography Colonography in Screening and Staging of Colorectal Cancers | 34 | ||
| SUMMARY | 35 | ||
| REFERENCES | 35 | ||
| Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies | 39 | ||
| Key points | 39 | ||
| INTRODUCTION | 39 | ||
| VARIOUS TECHNIQUES TO MINIMIZE BLADDER ACTIVITY | 40 | ||
| URINARY BLADDER CANCER | 40 | ||
| CERVICAL CANCER | 43 | ||
| OVARIAN CANCER | 44 | ||
| SUMMARY | 44 | ||
| REFERENCES | 45 | ||
| Role of PET/Computed Tomography in Radiofrequency Ablation for Malignant Pulmonary Tumors | 47 | ||
| Key points | 47 | ||
| INTRODUCTION | 47 | ||
| CLINICAL BACKGROUND | 48 | ||
| Non–Small Cell Lung Cancer | 48 | ||
| Metastatic Lung Tumor | 48 | ||
| Other Pulmonary Malignant Tumors | 48 | ||
| INDICATIONS FOR RADIOFREQUENCY ABLATION OF PULMONARY MALIGNANT TUMORS | 48 | ||
| RADIOFREQUENCY ABLATION TECHNIQUE AND EXPECTED COMPLICATIONS | 49 | ||
| PROGNOSIS AFTER RADIOFREQUENCY ABLATION FOR PULMONARY MALIGNANCIES | 49 | ||
| IMAGING PROTOCOL | 49 | ||
| IMAGING FINDINGS | 50 | ||
| IMAGING COMPARISON BETWEEN FLUORODEOXYGLUCOSE-PET AND COMPUTED TOMOGRAPHY SCAN | 50 | ||
| OPTIMAL FOLLOW-UP SCHEDULE WITH FLUORODEOXYGLUCOSE-PET | 51 | ||
| EVALUATION OF RECURRENCE AFTER RADIOFREQUENCY ABLATION | 52 | ||
| PITFALLS | 52 | ||
| FUTURE DIRECTIONS OF RADIOFREQUENCY ABLATION AND RADIOGRAPHIC IMPROVEMENT FOR PULMONARY MALIGNANCIES | 52 | ||
| ACKNOWLEDGMENTS | 53 | ||
| REFERENCES | 54 | ||
| Fluorodeoxyglucose-PET/Computed Tomography–Guided Biopsy | 57 | ||
| Key points | 57 | ||
| HISTORY OF IMAGE-GUIDED BIOPSY | 57 | ||
| Ultrasound-Guided Biopsy | 57 | ||
| Computed Tomography–Guided Biopsy | 57 | ||
| MRI-Guided Biopsy | 58 | ||
| PET/Computed Tomography–Guided Biopsy | 58 | ||
| TECHNICAL PROCEDURE OF FLUORODEOXYGLUCOSE-PET/COMPUTED TOMOGRAPHY–GUIDED BIOPSY | 58 | ||
| Indications | 58 | ||
| Contraindications | 59 | ||
| Type of Biopsies | 59 | ||
| Procedure Description | 59 | ||
| Types of Access | 60 | ||
| Direct access | 60 | ||
| Oblique access | 61 | ||
| Bone and transbone approach | 61 | ||
| Transpulmonary approach to the mediastinal lesions | 61 | ||
| ACUTE COMPLICATIONS OF BIOPSY PROCEDURES | 61 | ||
| REFERENCES | 63 | ||
| Dual-time-point Imaging and Delayed-time-point Fluorodeoxyglucose-PET/Computed Tomography Imaging in Various Clinical Settings | 65 | ||
| Key points | 65 | ||
| INTRODUCTION | 65 | ||
| DYNAMIC CHANGES OF FLUORODEOXYGLUCOSE UPTAKE OVER TIME | 66 | ||
| APPLICATIONS OF DUAL-TIME-POINT IMAGING IN MALIGNANT DISEASES | 67 | ||
| Lung | 67 | ||
| Diagnostic role of dual-time-point imaging in lung cancer | 67 | ||
| Prognostic role of dual-time-point imaging in lung cancer | 68 | ||
| Role of dual-time-point imaging in lymph node staging of lung cancer | 74 | ||
| Breast | 75 | ||
| APPLICATIONS OF DUAL-TIME-POINT IMAGING IN NONMALIGNANT DISEASES | 76 | ||
| Inflammation/Infection of the Lung | 76 | ||
| Atherosclerosis | 77 | ||
| Brown Fat | 78 | ||
| Crohn Disease | 79 | ||
| CHALLENGES, SUMMARY, AND FUTURE DIRECTIONS | 79 | ||
| REFERENCES | 80 | ||
| Contrast Media in PET/Computed Tomography Imaging | 85 | ||
| Key points | 85 | ||
| INTRODUCTION | 85 | ||
| TYPES OF CONTRAST AGENTS | 86 | ||
| Intravenous Contrast Agents | 86 | ||
| Oral Contrast Agents | 88 | ||
| CONTRAST PET/COMPUTED TOMOGRAPHY PROTOCOLS | 90 | ||
| ADVERSE REACTIONS TO CONTRAST AGENTS | 90 | ||
| Severity of Reaction | 91 | ||
| CONTRAST-BASED SPECIAL TECHNIQUES IN PET/COMPUTED TOMOGRAPHY | 91 | ||
| PET/Computed Tomography Enteroclysis | 91 | ||
| Diuretic Fluorodeoxyglucose PET/Computed Tomography Scan | 92 | ||
| SUMMARY | 92 | ||
| REFERENCES | 93 |